KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$75.79
Tradestie Score
64
Market Cap
$2.86B
P/E Ratio
75.2
Revenue Growth
0.6%
Analyst Upside
+29.3%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$6.82
$7.83B - 44 Compare
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$92.83
$6.64B - 46 Compare
KRYS Krystal Biotech, Inc. Common Stock
$322.28
$5.20B 40.8 63 Compare
ALKS Alkermes Inc. plc
$41.75
$5.06B 106.7 62 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$82.93
$3.67B - 46 Compare
LNTH Lantheus Holdings, Inc
$99.96
$3.51B 23.8 56 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$46.81
$3.33B - 68 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$20.30
$3.26B 41.8 38 Compare
PBH Prestige Consumer Healthcare Inc.
$45.26
$3.12B 12.5 60 Compare
PRGO PERRIGO COMPANY PLC
$14.26
$3.10B - 33 Compare

Data updated: Oct 02, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry